131 related articles for article (PubMed ID: 11553365)
1. Involvement of Rho-kinase in vascular remodeling caused by long-term inhibition of nitric oxide synthesis in rats.
Ikegaki I; Hattori T; Yamaguchi T; Sasaki Y; Satoh SI; Asano T; Shimokawa H
Eur J Pharmacol; 2001 Sep; 427(1):69-75. PubMed ID: 11553365
[TBL] [Abstract][Full Text] [Related]
2. Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats.
Kataoka C; Egashira K; Inoue S; Takemoto M; Ni W; Koyanagi M; Kitamoto S; Usui M; Kaibuchi K; Shimokawa H; Takeshita A
Hypertension; 2002 Feb; 39(2):245-50. PubMed ID: 11847192
[TBL] [Abstract][Full Text] [Related]
3. Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats.
Numaguchi K; Egashira K; Takemoto M; Kadokami T; Shimokawa H; Sueishi K; Takeshita A
Hypertension; 1995 Dec; 26(6 Pt 1):957-62. PubMed ID: 7490155
[TBL] [Abstract][Full Text] [Related]
4. Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis.
Takemoto M; Egashira K; Tomita H; Usui M; Okamoto H; Kitabatake A; Shimokawa H; Sueishi K; Takeshita A
Hypertension; 1997 Dec; 30(6):1621-7. PubMed ID: 9403592
[TBL] [Abstract][Full Text] [Related]
5. Rho/Rho-kinase pathway in the brainstem contributes to hypertension caused by chronic nitric oxide synthase inhibition.
Ito K; Hirooka Y; Kishi T; Kimura Y; Kaibuchi K; Shimokawa H; Takeshita A
Hypertension; 2004 Feb; 43(2):156-62. PubMed ID: 14732730
[TBL] [Abstract][Full Text] [Related]
6. Fasudil, a Rho-kinase inhibitor, reverses L-NAME exacerbated severe nephrosclerosis in spontaneously hypertensive rats.
Koshikawa S; Nishikimi T; Inaba C; Akimoto K; Matsuoka H
J Hypertens; 2008 Sep; 26(9):1837-48. PubMed ID: 18698220
[TBL] [Abstract][Full Text] [Related]
7. Long-term treatment with N(omega)-nitro-L-arginine methyl ester causes arteriosclerotic coronary lesions in endothelial nitric oxide synthase-deficient mice.
Suda O; Tsutsui M; Morishita T; Tanimoto A; Horiuchi M; Tasaki H; Huang PL; Sasaguri Y; Yanagihara N; Nakashima Y
Circulation; 2002 Sep; 106(13):1729-35. PubMed ID: 12270870
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of nitric oxide synthesis induces coronary vascular remodeling and cardiac hypertrophy associated with the activation of p70 S6 kinase in rats.
Minamino T; Kitakaze M; Papst PJ; Ueda Y; Sakata Y; Asanuma H; Ogai A; Kuzuya T; Terada N; Hori M
Cardiovasc Drugs Ther; 2000 Oct; 14(5):533-42. PubMed ID: 11101202
[TBL] [Abstract][Full Text] [Related]
9. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats.
Takemoto M; Egashira K; Usui M; Numaguchi K; Tomita H; Tsutsui H; Shimokawa H; Sueishi K; Takeshita A
J Clin Invest; 1997 Jan; 99(2):278-87. PubMed ID: 9005996
[TBL] [Abstract][Full Text] [Related]
10. Long-term inhibition of Rho kinase with fasudil attenuates high flow induced pulmonary artery remodeling in rats.
Li F; Xia W; Li A; Zhao C; Sun R
Pharmacol Res; 2007 Jan; 55(1):64-71. PubMed ID: 17127075
[TBL] [Abstract][Full Text] [Related]
11. Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system.
Higashi M; Shimokawa H; Hattori T; Hiroki J; Mukai Y; Morikawa K; Ichiki T; Takahashi S; Takeshita A
Circ Res; 2003 Oct; 93(8):767-75. PubMed ID: 14500337
[TBL] [Abstract][Full Text] [Related]
12. Rho-kinase is involved in macrophage-mediated formation of coronary vascular lesions in pigs in vivo.
Miyata K; Shimokawa H; Kandabashi T; Higo T; Morishige K; Eto Y; Egashira K; Kaibuchi K; Takeshita A
Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2351-8. PubMed ID: 11073837
[TBL] [Abstract][Full Text] [Related]
13. Long-term inhibition of Rho-kinase induces a regression of arteriosclerotic coronary lesions in a porcine model in vivo.
Shimokawa H; Morishige K; Miyata K; Kandabashi T; Eto Y; Ikegaki I; Asano T; Kaibuchi K; Takeshita A
Cardiovasc Res; 2001 Jul; 51(1):169-77. PubMed ID: 11399259
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, NG-nitro-L-arginine.
Pfeiffer S; Leopold E; Schmidt K; Brunner F; Mayer B
Br J Pharmacol; 1996 Jul; 118(6):1433-40. PubMed ID: 8832069
[TBL] [Abstract][Full Text] [Related]
15. Acute Rho-kinase inhibition improves coronary dysfunction in vivo, in the early diabetic microcirculation.
Pearson JT; Jenkins MJ; Edgley AJ; Sonobe T; Joshi M; Waddingham MT; Fujii Y; Schwenke DO; Tsuchimochi H; Yoshimoto M; Umetani K; Kelly DJ; Shirai M
Cardiovasc Diabetol; 2013 Aug; 12():111. PubMed ID: 24059472
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis, coronary arterial remodeling, and myocardial infarction after nitric oxide inhibition in SHR.
Ono Y; Ono H; Matsuoka H; Fujimori T; Frohlich ED
Hypertension; 1999 Oct; 34(4 Pt 1):609-16. PubMed ID: 10523335
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide does not downregulate Rho-kinase (ROCK-2) expression in rat coronary endothelial cells.
Tiftik RN; Erol A; Cnar MG; Kubat H; Ark M; Ulker S; Büyükafşar K
J Cardiovasc Pharmacol; 2008 Feb; 51(2):140-7. PubMed ID: 18287881
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis.
Katoh M; Egashira K; Mitsui T; Chishima S; Takeshita A; Narita H
J Mol Cell Cardiol; 2000 Jan; 32(1):73-83. PubMed ID: 10652192
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Rho-kinase by fasudil restores the cardioprotection of ischemic postconditioninng in hypercholesterolemic rat heart.
Wu N; Li W; Shu W; Lv Y; Jia D
Mol Med Rep; 2014 Nov; 10(5):2517-24. PubMed ID: 25231456
[TBL] [Abstract][Full Text] [Related]
20. Reciprocal expression of vascular endothelial growth factor and nitric oxide synthase by coronary arterial wall cells during chronic inhibition of nitric oxide synthesis in rats.
Sakamoto H; Nakamura T; Akuzawa N; Masuda H; Sumino H; Saito Y; Ohyama Y; Kurashina T; Tamura J; Kurabayashi M
Nephron; 2002 Oct; 92(2):472-4. PubMed ID: 12218334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
